NCT06531564

Brief Summary

Comparison of emergency department management of patients presenting with isolated hip fracture: comparison of methods used in pain management, monitoring, and treatment; comparison of hospitalization durations; comparison of mortality

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
155

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 17, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 1, 2024

Completed
Last Updated

August 1, 2024

Status Verified

July 1, 2024

Enrollment Period

6 months

First QC Date

July 17, 2024

Last Update Submit

July 29, 2024

Conditions

Keywords

isolated femur fractureanalgesiaemergency departmentnerve block

Outcome Measures

Primary Outcomes (1)

  • effective analgesia after receiving treatment

    patients will be evaluated before and after analgesic treatments according to pain scales ( visual analogue scale, verbal pain intensity scale, PAINAD ( pain assessment in advanced dementia) scale andvisual analogue scale), effective pain management will be primary outcome

    24 hours

Study Arms (5)

Opioid group

patients receiving intravenous opioid agents after femur fracture

NSAID

patients receiving intravenous NSAID agents after femur fracture

acetaminophen

patients receiving intravenous acetaminophen after femur fracture

Femoral nerve block

patients receiving femoral nerve blocking treatment after femur fracture

PENG block

patients receiving PENG blocking treatment after femur fracture

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients over the age of 18 years administered to emergency department with isolated femur fracture receving analgesia

You may qualify if:

  • Patients over the age of 18 years

You may not qualify if:

  • Forensic cases Patients who do not have follow-up in our healthcare system or cannot be followed up Patients with allergies to opioids or local anesthetics Patients with suspected neuropathy among defined complications of diabetes mellitus Patients requiring treatment for ≥2 different types of fractures upon emergency department admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Etlik City Hospital

Ankara, Yenimahalle, 06110, Turkey (Türkiye)

Location

Related Publications (3)

  • Simic A, Nesek Adam V, Rosic D, Kocet N, Svetec M, Herceg A, Keranovic A, Rasic Z. PERIPHERAL NERVE BLOCKS FOR HIP FRACTURES IN EMERGENCY MEDICINE. Acta Clin Croat. 2022 Jun;61(Suppl 1):78-83. doi: 10.20471/acc.2022.61.s1.13.

    PMID: 36304813BACKGROUND
  • Thiam CN, Khor HM, Pang GHM, Lim WC, Shanmugam T, Chandrasekaran CSK, Singh S, Zakaria MIB, Ong T. Hip fracture management in the emergency department and its impact on hospital outcomes: a retrospective cross-sectional analysis. Eur Geriatr Med. 2022 Oct;13(5):1081-1088. doi: 10.1007/s41999-022-00654-0. Epub 2022 May 14.

    PMID: 35567676BACKGROUND
  • Fahey A, Cripps E, Ng A, Sweeny A, Snelling PJ. Pericapsular nerve group block for hip fracture is feasible, safe and effective in the emergency department: A prospective observational comparative cohort study. Emerg Med Australas. 2022 Dec;34(6):884-891. doi: 10.1111/1742-6723.14013. Epub 2022 Jun 14.

    PMID: 35701386BACKGROUND

MeSH Terms

Conditions

Femoral FracturesArthralgiaAgnosiaEmergencies

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesLeg InjuriesJoint DiseasesMusculoskeletal DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System DiseasesDisease AttributesPathologic Processes

Study Officials

  • gulsen akcay, ass. prof.

    ass. prof. of organization

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2024

First Posted

August 1, 2024

Study Start

August 1, 2023

Primary Completion

February 1, 2024

Study Completion

February 1, 2024

Last Updated

August 1, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations